The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Freek Verheugt
Showing 1-7 of 7 articles
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial
Serruys P,
Tomaniak M,
Chichareon P,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Spitzer E,
Walsh S,
Adlam D,
Hildick-Smith D,
Édes I,
van de Harst P,
Krackhardt F,
Tijssen J,
Rademaker-Havinga T,
Garg S,
Steg P,
Hamm C,
Jüni P,
Vranckx P,
Onuma Y,
Verheugt F
December 20, 2019 | 10.4244/EIJ-D-19-00202
Bivalirudin in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: uncertainties almost clarified
Huber K,
Verheugt F
March 20, 2017 | 10.4244/EIJV12I16A315
Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial
Dewilde W,
Janssen P,
Kelder J,
Verheugt F,
de Smet B,
Adrianssens T,
Vrolix M,
Brueren G,
Vandendriessche T,
van Mieghem C,
Cornelis K,
Vos J,
Breet N,
ten Berg J
August 20, 2015 | 10.4244/EIJY14M06_07
A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients
Vranckx P,
Verheugt F,
de Maat MP,
Ulmans V,
Regar E,
Smits P,
ten Berg J,
Lindeboom W,
Jones R,
Friedman J,
Reilly P,
Leebeek F
January 18, 2013 | 10.4244/EIJV8I9A162
Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study
Hamon M,
Rao S,
Steg G,
Valgimigli M,
Verheugt F,
Marso S,
Gershlick A,
Wang Y,
Deliargyris E
August 24, 2012 | 10.4244/EIJV8I4A76
Triggering mechanisms of stent thrombosis
Zwart B,
van Werkum J,
Heestermans A,
Kelder J,
Zomer A,
van't Hof A,
Verheugt F,
ten Berg J
January 20, 2011
Effect of PCI on inflammatory markers, adiponectin and insulin resistance
Gomes M,
Smits P,
Verheugt F,
Tack C
February 25, 2010
1
Latest news
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
EUROPCR LATE BREAKING
SavvyWire in TAVI
FREE ARTICLE - Josep Rodés-Cabau et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke